Skip to main content
Erschienen in: Diabetologia 10/2012

01.10.2012 | Article

The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk

verfasst von: B. M. Kaess, A. Pedley, J. M. Massaro, J. Murabito, U. Hoffmann, C. S. Fox

Erschienen in: Diabetologia | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The anatomic location of excess body fat has an impact on associated cardiometabolic morbidity, and visceral adipose tissue (VAT) is more pathogenic than subcutaneous adipose tissue (SAT). However, VAT or SAT alone provides little information regarding the relative distribution of body fat. We hypothesised that the propensity to store energy in VAT relative to SAT depots may be a correlate of cardiometabolic risk, and tested this hypothesis using the VAT/SAT ratio as a metric of fat distribution.

Methods

We investigated associations of the VAT/SAT ratio with cardiometabolic traits in 3,223 participants (48% women) from the Framingham Heart Study. Fat depots were quantified by multidetector computed tomography (CT) scanning.

Results

In women and men, higher VAT/SAT ratio was associated (p < 0.05) with most assessed cardiovascular risk factors reflecting blood pressure, dyslipidaemia and insulin resistance. Additional adjustment for BMI did not materially change the findings in women, and generally strengthened associations in men. Further adjustment for VAT attenuated some associations in women, but those with lower HDL-cholesterol, higher triacylglycerol (both p < 0.0001) and higher prevalence of hypertension (p = 0.02), diabetes (p = 0.01) and the metabolic syndrome (p = 0.005) remained significant. Similarly, in men, associations with higher systolic (p = 0.006) and diastolic blood pressure (p = 0.03), higher fasting glucose (p = 0.0005), lower HDL-cholesterol and higher triacylglycerol (both p < 0.0001) and higher prevalence of diabetes (p = 0.006) remained significant.

Conclusions/interpretation

VAT/SAT ratio is a correlate of cardiometabolic risk, above and beyond BMI and VAT. The propensity to store fat viscerally versus subcutaneously may be a unique risk factor independent of absolute fat volumes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA et al (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79PubMedCrossRef Mokdad AH, Ford ES, Bowman BA et al (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79PubMedCrossRef
2.
Zurück zum Zitat Kaess BM, Jozwiak J, Mastej M et al (2010) Association between anthropometric obesity measures and coronary artery disease: a cross-sectional survey of 16,657 subjects from 444 Polish cities. Heart 96:131–135PubMedCrossRef Kaess BM, Jozwiak J, Mastej M et al (2010) Association between anthropometric obesity measures and coronary artery disease: a cross-sectional survey of 16,657 subjects from 444 Polish cities. Heart 96:131–135PubMedCrossRef
3.
Zurück zum Zitat Liu J, Fox CS, Hickson DA et al (2010) Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 95:5419–5426PubMedCrossRef Liu J, Fox CS, Hickson DA et al (2010) Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 95:5419–5426PubMedCrossRef
4.
Zurück zum Zitat Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48PubMedCrossRef Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48PubMedCrossRef
5.
Zurück zum Zitat Tran TT, Yamamoto Y, Gesta S, Kahn CR (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410–420PubMedCrossRef Tran TT, Yamamoto Y, Gesta S, Kahn CR (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410–420PubMedCrossRef
6.
Zurück zum Zitat Porter SA, Massaro JM, Hoffmann U, Vasan RS, O’Donnel CJ, Fox CS (2009) Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32:1068–1075PubMedCrossRef Porter SA, Massaro JM, Hoffmann U, Vasan RS, O’Donnel CJ, Fox CS (2009) Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32:1068–1075PubMedCrossRef
7.
Zurück zum Zitat Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP (1979) An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110:281–290PubMed Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP (1979) An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110:281–290PubMed
8.
Zurück zum Zitat Splansky GL, Corey D, Yang Q et al (2007) The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 165:1328–1335PubMedCrossRef Splansky GL, Corey D, Yang Q et al (2007) The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 165:1328–1335PubMedCrossRef
9.
Zurück zum Zitat Preis SR, Massaro JM, Robins SJ et al (2010) Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 18:2191–2198CrossRef Preis SR, Massaro JM, Robins SJ et al (2010) Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 18:2191–2198CrossRef
10.
Zurück zum Zitat Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O’Donnell CJ, Hoffmann U (2007) Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 31:500–506CrossRef Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O’Donnell CJ, Hoffmann U (2007) Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 31:500–506CrossRef
11.
12.
Zurück zum Zitat Heilbronn L, Smith SR, Ravussin E (2004) Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28(Suppl 4):S12–S21PubMedCrossRef Heilbronn L, Smith SR, Ravussin E (2004) Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28(Suppl 4):S12–S21PubMedCrossRef
13.
Zurück zum Zitat Bjorntorp P (1990) 'Portal’ adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493–496PubMedCrossRef Bjorntorp P (1990) 'Portal’ adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493–496PubMedCrossRef
14.
Zurück zum Zitat Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K (1995) Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 3(Suppl 2):187S–194SPubMed Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K (1995) Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 3(Suppl 2):187S–194SPubMed
15.
Zurück zum Zitat Lee MJ, Gong DW, Burkey BF, Fried SK (2010) Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am J Physiol Endocrinol Metab 300:E571–E580PubMedCrossRef Lee MJ, Gong DW, Burkey BF, Fried SK (2010) Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am J Physiol Endocrinol Metab 300:E571–E580PubMedCrossRef
16.
Zurück zum Zitat Miyazaki Y, Mahankali A, Matsuda M et al (2002) Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784–2791PubMedCrossRef Miyazaki Y, Mahankali A, Matsuda M et al (2002) Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784–2791PubMedCrossRef
17.
Zurück zum Zitat Akazawa S, Sun F, Ito M, Kawasaki E, Eguchi K (2000) Efficacy of troglitazone on body fat distribution in type 2 diabetes. Diabetes Care 23:1067–1071PubMedCrossRef Akazawa S, Sun F, Ito M, Kawasaki E, Eguchi K (2000) Efficacy of troglitazone on body fat distribution in type 2 diabetes. Diabetes Care 23:1067–1071PubMedCrossRef
18.
Zurück zum Zitat Nakamura T, Funahashi T, Yamashita S et al (2001) Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation – double-blind placebo-controlled trial. Diabetes Res Clin Pract 54:181–190PubMedCrossRef Nakamura T, Funahashi T, Yamashita S et al (2001) Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation – double-blind placebo-controlled trial. Diabetes Res Clin Pract 54:181–190PubMedCrossRef
19.
Zurück zum Zitat Yang X, Smith U (2007) Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 50:1127–1139PubMedCrossRef Yang X, Smith U (2007) Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 50:1127–1139PubMedCrossRef
20.
Zurück zum Zitat Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351:871–875PubMedCrossRef Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351:871–875PubMedCrossRef
21.
Zurück zum Zitat Troll JG (2011) Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection. Curr Atheroscler Rep 13:51–56PubMedCrossRef Troll JG (2011) Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection. Curr Atheroscler Rep 13:51–56PubMedCrossRef
22.
Zurück zum Zitat Carr A, Samaras K, Burton S et al (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51–F58PubMedCrossRef Carr A, Samaras K, Burton S et al (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51–F58PubMedCrossRef
23.
Zurück zum Zitat Gastaldelli A, Sironi AM, Ciociaro D et al (2005) Visceral fat and beta cell function in non-diabetic humans. Diabetologia 48:2090–2096PubMedCrossRef Gastaldelli A, Sironi AM, Ciociaro D et al (2005) Visceral fat and beta cell function in non-diabetic humans. Diabetologia 48:2090–2096PubMedCrossRef
24.
Zurück zum Zitat Molenaar EA, Massaro JM, Jacques PF et al (2009) Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the Framingham Heart Study. Diabetes Care 32:505–510PubMedCrossRef Molenaar EA, Massaro JM, Jacques PF et al (2009) Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the Framingham Heart Study. Diabetes Care 32:505–510PubMedCrossRef
25.
Zurück zum Zitat Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305–1309PubMedCrossRef Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305–1309PubMedCrossRef
26.
Zurück zum Zitat Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson JA (2012) The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol 212:3–12PubMedCrossRef Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson JA (2012) The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol 212:3–12PubMedCrossRef
27.
Zurück zum Zitat Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG (1989) The effect of nicotine on energy expenditure during light physical activity. N Engl J Med 320:898–903PubMedCrossRef Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG (1989) The effect of nicotine on energy expenditure during light physical activity. N Engl J Med 320:898–903PubMedCrossRef
28.
Zurück zum Zitat Mineur YS, Abizaid A, Rao Y et al (2011) Nicotine decreases food intake through activation of POMC neurons. Science 332:1330–1332PubMedCrossRef Mineur YS, Abizaid A, Rao Y et al (2011) Nicotine decreases food intake through activation of POMC neurons. Science 332:1330–1332PubMedCrossRef
29.
Zurück zum Zitat Miyazaki Y, DeFronzo RA (2009) Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol 8:44PubMedCrossRef Miyazaki Y, DeFronzo RA (2009) Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol 8:44PubMedCrossRef
30.
Zurück zum Zitat He H, Ni Y, Chen J et al (2011) Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res 155:71–77CrossRef He H, Ni Y, Chen J et al (2011) Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res 155:71–77CrossRef
31.
Zurück zum Zitat Gorgey AS, Mather KJ, Gater DR (2011) Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury. Metabolism 60:843–851PubMedCrossRef Gorgey AS, Mather KJ, Gater DR (2011) Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury. Metabolism 60:843–851PubMedCrossRef
32.
Zurück zum Zitat Kim S, Cho B, Lee H et al (2011) Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population. Diabetes Care 34:504–506PubMedCrossRef Kim S, Cho B, Lee H et al (2011) Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population. Diabetes Care 34:504–506PubMedCrossRef
Metadaten
Titel
The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk
verfasst von
B. M. Kaess
A. Pedley
J. M. Massaro
J. Murabito
U. Hoffmann
C. S. Fox
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2639-5

Weitere Artikel der Ausgabe 10/2012

Diabetologia 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.